TELA Bio, Inc. (TELA) NASDAQ

0.91

+0.01(+1.11%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap55.4M
Enterprise Value60.21M
P/E Ratio-1.31
PEG Ratio-0.02
Price/Sales Ratio0.5
Price/Book Ratio-10.02
Enterprise/Revenue0.71
Enterprise/EBITDA-1.74

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.49
Operating Margin-0.42

Management Effectiveness

Return On Assets-0.57
Return On Equity-13.44

Income Statement

Revenue80.28M
Revenue/Share1.41
Gross Profit54.34M
EBITDA-33.76M
Net Income-38.83M
Diluted EPS-0.83

Balance Sheet

Total Cash39.54M
Total Cash/Share0.69
Total Debt55.87M
Total Debt/Equity-10.74
Current Ratio3.61
Book Value Per Share-0.09

Price History

52-Week Change-35.92
52-Week High2.2
52-Week Low0.5
Moving Average 50 Days0.79
Moving Average 200 Days1.11

Statistics

Average Volume184,180
Shares Outstanding44.77M
% Held by Institutions57.24

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A